News | June 23, 2008

Implantable Cardiac Devices Link Up with Medtronic Network

June 25, 2008 - Medtronic reported that all Vision 3D implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds) are now compatible with the Medtronic CareLink Network.

The Medtronic CareLink Network is designed to allow physicians to perform a complete analysis of all the device- and patient-specific cardiac data stored within Medtronic implantable cardiac devices. With this announcement, all current models of Medtronic ICDs, CRT-Ds and pacemakers are compatible with the Medtronic CareLink Network, which has registered more than 1 million patient data transmissions since its inception.

The Medtronic CareLink Network helps physicians and patients better manage chronic cardiovascular disease treated by implantable device therapy. It is said to enable the transmission of patient and implanted device data using a portable monitor. Within minutes, the patient’s physician and nurses can view the data on a secure Internet Web site.
For heart failure patients with Medtronic devices equipped with Conexus Wireless Telemetry – all Vision 3D ICDs and CRT-Ds, as well as Concerto CRT-Ds or Virtuoso ICDs – a Medtronic CareAlert Notification can be sent via the Medtronic CareLink Network to physicians wirelessly and automatically, providing timely insight into a patient’s changing disease condition and the potential for treatment decisions before the condition worsens.
The transmitted information, which is comparable to that provided during an in-clinic device follow-up visit, provides the physician with a view of how both the device and patient’s heart are operating.
The system provides an efficient, safe and convenient way for specialty physicians to remotely monitor the condition of their patients and, if needed, make adjustments to medication or prescribe additional therapy.
It also saves patients time by potentially eliminating some in-office visits.

For more information: www.medtronic.com


Related Content

News | Implantable Cardioverter Defibrillator (ICD)

February 12, 2024 — BIOTRONIK, a leader in implantable medical device technology, announced today they will solely ...

Home February 12, 2024
Home
News | Implantable Cardioverter Defibrillator (ICD)

October 23, 2023 — Medtronic plc, a global leader in healthcare technology, has received U.S. Food and Drug ...

Home October 23, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 28, 2023 — Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial ...

Home August 28, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 28, 2023 — Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and ...

Home August 28, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Medtronic ICDs and CRT-Ds ...

Home July 18, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no ...

Home March 07, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

February 17, 2023 — Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan ...

Home February 17, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...

Home August 29, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 18, 2022 — A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients ...

Home August 18, 2022
Home
Subscribe Now